SGRY - NASDAQ

Surgery Partners, Inc.

SGRY·NASDAQ

$13.51

+2.2%

HealthcareMedical - Care Facilities

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and ancillary services, which consist of multi-specialty physician practices, urgent care facilities, and anesthesia services. As of December 31, 2021, it owned or operated a portfolio of 126 surgical facilities, including 108 ambulatory surgical centers and 18 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.77B

EPS-0.6100

P/E Ratio-22.15

Earnings Date08/04/2026

8.24B

Assets

3Y+23.0%

5Y+52.0%

10Y+258.0%

4.72B

Total Liabilities

11%

3Y+39.0%

5Y+24.0%

10Y+105.0%

3.53B

Total Equity

-3%

3Y+7.0%

5Y+117.0%

10Y+986.0%

Surgery Partners, Inc. Funding & Solvency Profile

SGRY · NASDAQ

Current Assets

Cash & Cash Equivalents239.90M

Net Receivables602.20M

Inventory96.60M

Other Current Assets170.90M

Total Current Assets1 B

Non-Current Assets

Property, Plant & Equipment1.44B

Goodwill & Intangible Assets5.24B

Long-Term Investments234.00M

Other Non-Current Assets56.80M

Total Non-Current Assets2 B

Total Assets

8.24B

Financial Health Analysis

Current Ratio

1.87x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

1.34x

Elevated leverage. Debt exceeds equity, which amplifies both gains and risks. Monitor debt servicing ability.

Working Capital

535 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

14% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Surgery Partners, Inc. Balance Sheet

SGRY • NASDAQ

Surgery Partners, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	239.9M	269.5M	195.9M	282.9M	389.9M	317.9M	92.7M	184.3M	174.9M	69.7M	57.9M	74.9M	13M
Cash & Short-Term Investments	239.9M	269.5M	195.9M	282.9M	389.9M	317.9M	92.7M	184.3M	174.9M	69.7M	57.9M	74.9M	13M
Net Receivables	602.2M	579.1M	496.4M	456.3M	430.2M	382.2M	326.9M	316.1M	295.6M	227.6M	186.2M	153.6M	62.5M
Accounts Receivables	602.2M	579.1M	496.4M	456.3M	430.2M	382.2M	326.9M	316.1M	295.6M	220.6M	186.2M	145M	54.4M
Other Receivables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7M	0.0	0.0	0.0
Inventory	96.6M	88.4M	75.2M	71.4M	61.1M	56.4M	46.3M	43.4M	45M	28.8M	25.6M	23.7M	4.6M
Prepaids	41.1M	0.0	31M	31.4M	25.6M	17.6M	17.8M	16.2M	16.8M	11.2M	7.4M	7.1M	1.6M
Other Current Assets	170.9M	182.4M	96.5M	79M	39.3M	27.4M	41.8M	28.3M	30.9M	24.7M	33.8M	18M	8.9M
Total Current Assets	1.2B	1.1B	895M	921M	946.1M	801.5M	525.5M	588.3M	563.2M	362M	311M	268.6M	82.5M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	1.4B	1.4B	1.2B	1.2B	953.8M	854.7M	821M	426.3M	398.5M	204.3M	184.6M	175M	20.8M
Goodwill	5.2B	5.1B	4.3B	4.1B	3.9B	3.5B	3.4B	3.4B	3.3B	1.6B	1.4B	1.3B	339.5M
Intangible Assets	41M	45.7M	54.8M	42.3M	43.7M	46.9M	47.3M	54.3M	58.9M	48M	53.6M	54.9M	27M
Goodwill & Intangible Assets	5.2B	5.1B	4.4B	4.2B	4B	3.5B	3.4B	3.4B	3.4B	1.6B	1.5B	1.4B	366.5M
Long-Term Investments	234M	215.4M	184.1M	190.3M	88.7M	90.3M	93.2M	78.5M	74.3M	35M	34.1M	33.4M	0.0
Tax Assets	122.3M	0.0	89.5M	91.5M	114.4M	124.8M	98.7M	109.2M	132.3M	83.8M	94.1M	3.8M	0.0
Other Non-Current Assets	56.8M	57.5M	103.3M	144.2M	59.1M	27M	31.3M	36.9M	48.7M	16.8M	21.5M	24.3M	4.9M
Total Non-Current Assets	7.1B	6.8B	6B	5.8B	5.2B	4.6B	4.5B	4.1B	4.1B	1.9B	1.8B	1.6B	392.2M
Total Assets	8.2B	7.9B	6.9B	6.7B	6.1B	5.4B	5B	4.7B	4.6B	2.3B	2.1B	1.9B	474.7M
LIABILITIES
CURRENT LIABILITIES
Total Payables	208.7M	240.5M	195.7M	183.5M	150.9M	121.1M	96.7M	103.3M	89.6M	49.8M	45.3M	43.1M	18.3M
Accounts Payable	208.7M	208.7M	171.8M	151.6M	124.9M	100.2M	96.7M	83.3M	84.7M	49.8M	45.3M	43.1M	18.3M
Other Payables	0.0	31.8M	23.9M	31.9M	26M	20.9M	0.0	20M	9.8M	0.0	0.0	0.0	0.0
Accrued Expenses	64.9M	216.7M	192.5M	158.3M	173.7M	184.2M	134M	55.2M	135.2M	83.4M	58.4M	51.9M	11M
Short Term Debt	142M	101.4M	73.3M	62.8M	60.4M	64.4M	56M	55.6M	58.7M	27.8M	27.3M	22.1M	8.8M
Capital Lease Obligations (Current)	0.0	41M	37.6M	36.5M	40.1M	39.2M	37.3M	0.0	0.0	0.0	966K	0.0	0.0
Tax Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9M	2.6M	2M	3.2M	285K
Deferred Revenue	0.0	0.0	0.0	3.2M	64.4M	109.8M	-190M	-138.8M	-143.4M	-77.6M	-72.6M	59M	0.0
Other Current Liabilities	199.9M	24.8M	23.9M	49.1M	47.3M	38.1M	74.1M	135.2M	19.5M	25.7M	49.4M	24.4M	4.3M
Total Current Liabilities	615.5M	624.4M	523M	493.4M	536.8M	556.8M	397.6M	349.3M	303M	186.7M	181.3M	141.4M	42.5M
NON-CURRENT LIABILITIES
Long Term Debt	2.7B	3.3B	2.7B	2.6B	2.9B	2.8B	2.5B	2.3B	2.1B	1.4B	1.2B	1.4B	418.6M
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	-122.9M	-52.3M	-28.4M	-120.6M	-64M	18.2M	0.0
Deferred Tax Liabilities (Non-Current)	175.7M	39.2M	0.0	0.0	0.0	0.0	122.9M	52.3M	28.4M	122.4M	64M	49.2M	16M
Other Non-Current Liabilities	41.2M	30.2M	41.1M	75.4M	87M	139.7M	113.6M	121.5M	100.9M	198.6M	211.5M	35.5M	12M
Total Non-Current Liabilities	4.1B	3.6B	3B	2.9B	3.3B	3.2B	2.9B	2.5B	3B	1.6B	1.4B	1.5B	446.6M
Other Liabilities	0.0	0.0	0.0	0.0	0.0	0.0	1.7B	1.8B	1.3B	505.2M	481.4M	0.0	0.0
Capital Lease Obligations	1.2B	333.1M	286.5M	307.9M	355.7M	340.1M	320.4M	149.8M	133.5M	54.3M	55.9M	53.2M	0.0
Total Liabilities	4.7B	4.3B	3.5B	3.4B	3.8B	3.8B	5B	4.7B	4.6B	2.3B	2.1B	1.6B	489.1M
SHAREHOLDERS' EQUITY
Treasury Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33K	0.0	0.0	0.0	0.0	0.0
Preferred Stock	0.0	0.0	0.0	0.0	0.0	434.5M	395M	359.3M	330.8M	0.0	0.0	0.0	0.0
Common Stock	1.3M	1.3M	1.3M	1.3M	900K	500K	500K	489K	487K	485K	482K	0.0	0.0
Additional Paid-In Capital	2.5B	2.5B	2.5B	2.5B	1.6B	607.9M	662.7M	673.5M	695.6M	320.5M	316.3M	58.2M	59.7M
Retained Earnings	-815.2M	-737.3M	-569.2M	-557.3M	-502.7M	-431.8M	-315.7M	-247M	-41.3M	-311.4M	-320.8M	-322.2M	-163.3M
Accumulated Other Comprehensive Income/Loss	-13.8M	4.8M	57.5M	76.2M	-31.5M	-61M	-50.7M	-22.4M	-19.7M	-86.4M	-70.2M	-55.7M	-17.2M
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-359.3M	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	1.7B	1.8B	2B	2B	1.1B	550.1M	297.8M	404.6M	654.7M	9.7M	-4M	-264.1M	-103.6M
Total Equity	3.5B	3.6B	3.4B	3.3B	2.3B	1.6B	984.4M	1.1B	1.3B	324.7M	297.9M	222.1M	-14.4M
Minority Interest	1.8B	1.8B	1.4B	1.3B	1.2B	1.1B	686.6M	694.3M	681.9M	315M	302M	486.2M	89.2M
SUMMARY
Total Liabilities & Equity	8.2B	7.9B	6.9B	6.7B	6.1B	5.4B	5B	4.7B	4.6B	2.3B	2.1B	1.9B	474.7M
Total Investments	234M	215.4M	184.1M	190.3M	88.7M	90.3M	93.2M	78.5M	74.3M	35M	34.1M	33.4M	0.0
Total Debt	4B	3.7B	3.1B	2.9B	3.3B	3.2B	2.9B	2.5B	2.2B	1.5B	1.3B	1.4B	427.4M
Net Debt	3.8B	3.4B	2.9B	2.6B	2.9B	2.9B	2.8B	2.3B	2B	1.4B	1.3B	1.3B	414.4M
Shares Outstanding	128,209,410	128,209,410	128,209,410	128,209,410	128,209,410	128,209,410	128,209,410	128,209,410	128,209,410	128,209,410	128,209,410	128,209,410	128,209,410

SEC Filings

SGRY - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-Q 10-Q 2026 Q1 Q1	May 05, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 05, 2026	May 05, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 23, 2026	June 05, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 02, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	March 02, 2026	March 02, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 16, 2025	December 16, 2025	2025	View Filing
8-K 8-K 2025 N/A	December 12, 2025	December 11, 2025	2025	View Filing
8-K 8-K 2025 N/A	December 11, 2025	December 11, 2025	2025	View Filing
8-K 8-K 2025 N/A	November 12, 2025	November 12, 2025	2025	View Filing
10-Q 10-Q 2025 Q3 Q3	November 10, 2025	September 30, 2025	2025	View Filing

Showing 1 to 10 of 196 filings

Related Guides

Blog Categories

Continue your SGRY research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.